As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Moderator
-
Robert F. Sidonio Jr, MD, MSc
Assistant Professor of Pediatrics
Emory University and Aflac Cancer and
Blood Disorders Center
Atlanta, Georgia
The opinions expressed are those of Dr Sidonio and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Sidonio's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
-
Stacy E. Croteau, MD, MMS
Associate Professor in Pediatrics
Harvard Medical School
Associate Director
Boston Hemophilia Center
Boston Children's Hospital
Boston, Massachusetts
-
Chris Guelcher, RN-BC, MS, PPCNP-BC
Lead Advanced Practice Provider
Center for Cancer and Blood Disorders
Children's National Health System
Washington, DC
Editor
CME Reviewer
CME Reviewer / Nurse Planner
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
CME / ABIM MOC / CE
Prophylaxis in von Willebrand Disease: Is It Time for a New Perspective?
- Authors: Robert F. Sidonio, Jr, MD, MSc; Stacy E. Croteau, MD, MMS; Chris Guelcher, RN-BC, MS, PPCNP-BC
- CME / ABIM MOC / CE Released: 8/19/2019
- THIS ACTIVITY HAS EXPIRED FOR CREDIT
- Valid for credit through: 8/19/2020, 11:59 PM EST
Target Audience and Goal Statement
This activity is intended for hematologists, pediatricians, primary care physicians, nurse practitioners, nurses, and other clinicians involved in the diagnosis and management of von Willebrand disease (vWD).
The goal of this activity is to discuss the management of patients with von Willebrand Disease (vWD) and examine the emerging role of prophylaxis in the management of vWD.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Current recommendations for the management/prevention of bleeding episodes in patients with vWD
- Unmet needs in the management/prevention of bleeding episodes in patients with vWD
- Emerging prophylaxis strategies for patients with vWD
- Optimization of management strategies across the interprofessional care team in vWD
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Moderator
-
Robert F. Sidonio Jr, MD, MSc
Assistant Professor of Pediatrics
Emory University and Aflac Cancer and
Blood Disorders Center
Atlanta, Georgia
The opinions expressed are those of Dr Sidonio and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Sidonio's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
-
Stacy E. Croteau, MD, MMS
Associate Professor in Pediatrics
Harvard Medical School
Associate Director
Boston Hemophilia Center
Boston Children's Hospital
Boston, Massachusetts
-
Chris Guelcher, RN-BC, MS, PPCNP-BC
Lead Advanced Practice Provider
Center for Cancer and Blood Disorders
Children's National Health System
Washington, DC
Editor
CME Reviewer
CME Reviewer / Nurse Planner
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Accreditation Statements
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
-
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
For Physicians
-
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.
For Nurses
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
Prophylaxis in von Willebrand Disease: Is It Time for a New Perspective?
processing....
Assessment Survey
